Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2024年5月30日
	新闻
	Summit Therapeutics' stock surges as lung-cancer treatment vies with Merck's blockbuster Morningstar The trial compared the Summit drug, ivonescimab, with Keytruda in patients with non-small cell lung cancer whose tumors have positive expression of ... 标记为不相关
	CT-Based AI Model May Enhance Prediction of Lung Cancer Recurrence Diagnostic Imaging Can emerging artificial intelligence (AI) models improve the prediction of postoperative lung cancer recurrence? In a recent retrospective study, ... 标记为不相关
	Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study - Yahoo Finance Yahoo Finance ... lung cancer.Most Read from BloombergWorld's Largest Nuclear Plant Sits Idle While Energy Needs SoarSouth Africa Election Results With 29% Voting ... 标记为不相关
	Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study - Bloomberg News Bloomberg News Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its goal in patients with non-small cell lung cancer. 标记为不相关
	Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study - BNN Bloomberg BNN Bloomberg ... lung cancer. The Miami-based company said Thursday that its drug, ivonescimab, showed "a statistically significant and clinically meaningful ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈